Dividendový výnos spoločnosti Ayala Pharmaceuticals
Aká je hodnota metriky Dividendový výnos spoločnosti Ayala Pharmaceuticals?
Hodnota metriky Dividendový výnos spoločnosti Ayala Pharmaceuticals Inc. je N/A
Aká je definícia metriky Dividendový výnos?
Dividendový výnos (Dividend yield) je pomer vyplatených dividendov na jednu akciu za posledný rok a trhovej hodnoty jednej akcie v percentách.
The dividend yield or dividend-price ratio of a share is the dividend per share, divided by the price per share. It is also a company's total annual dividend payments divided by its market capitalization, assuming the number of shares is constant, and is often expressed as a percentage. The reciprocal of the dividend yield is the price-dividend ratio.
A higher dividend yield has been considered to be desirable among many investors. A high dividend yield can be considered to be evidence that a stock is underpriced or that the company has fallen on hard times and future dividends will not be as high as previous ones. Similarly a low dividend yield can be considered evidence that the stock is overpriced or that future dividends might be higher. Some investors may find a higher dividend yield attractive, for instance as an aid to marketing a fund to retail investors, or maybe because they cannot get their hands on the capital, which may be tied up in a trust arrangement. In contrast some investors may find a higher dividend yield unattractive, perhaps because it increases their tax bill.
Čomu sa venuje spoločnosť Ayala Pharmaceuticals?
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.